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Recently a stimulatory effect of atria1 natriuretic peptide (ANP) on the particulate guanylate cyclase system 
has been reported in the glomeruli from different species. Using cultures of homogeneous human glomerular 
cell lines, we found that rat and human ANP stimulated markedly cGMP formation in epithelial cells with 
a threshold dose of 1 nM. A 20-fold increase was obtained at 5 ,uM. Stimulation was also present but less 
substantial (Zfold at 5 PM) in mesangial cells. cGMP was formed rapidly and released in the medium. ANP 
and sodium nitroprusside, an activator of soluble guanylate cyclase, had additive effects on cGMP forma- 
tion. ANP did not inhibit CAMP formation in both cell lines. These results demonstrate that, at least in 
the human species, epithelial cells represent he main target of ANP in the glomerulus. Synthesis of cGMP 
in the glomerular epithelial cells in response to ANP also suggests that the xcess of urinary cGMP produced 
by the kidney which is observed after ANP administration is of glomerular rather than of tubular origin. 
Atria1 natriuretic factor cyclic GMP (Glomerulus, Epithelial cell) 
1. INTRODUCTION 
Atrial natriuretic peptides (ANP) stimulate renal 
excretion of water and sodium. Increase in 
glomerular filtration rate (GFR) appears to be the 
major mechanism responsible for natriuresis. In 
many studies, GFR rose by 30-50% [l-4]. The 
mechanisms for the change in GFR are still 
unknown. Increased renal plasma flow can be 
ruled out since it decreased or remained unchanged 
after ANP administration [1,2]. Thus, ANP 
enhances GFR by other mechanisms uch as in- 
creases of glomerular filtration surface area, 
glomerular capillary permeability or capillary 
hydraulic pressure. The latter effect has been 
recently demonstrated in the rat using micropunc- 
ture techniques [5]. In vitro studies have also con- 
tributed to analysis of the mode of action of ANP 
in glomeruli. ANP binds specifically to rat 
glomeruli [6,7] and stimulates cGMP formation in 
* To whom correspondence should be addressed 
rat [6] and dog [8,9] glomeruli. Activation of the 
particulate but not the soluble guanylate cyclase is 
responsible for this effect [8]. The greatest ac- 
cumulation of cGMP in the kidney has been 
observed in the glomeruli whereas there was no 
change in the proximal tubule [8,9] and only slight 
increases in the thick segment of the ascending 
limb of the loop of Henle and in the collecting 
tubule [8]. In contrast, with renal tubular epithelial 
cells, vascular smooth muscle cells respond to 
ANP by marked cGMP generation [lo, 111. These 
results suggested that glomerular mesangial cells 
which possess many of the properties of smooth 
muscle cells should be the target of ANP within the 
glomeruli. In agreement with this hypothesis, 
Ballerman et al. [6] demonstrated recently that 
ANP bound to rat mesangial cells and stimulated 
markedly cGMP formation in these cells. A func- 
tional response was also observed in glomerular 
epithelial cells but was considerably smaller. We 
have previously reported that ANP stimulated par- 
ticulate guanylate cyclase in human glomeruli [ 121. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/%3.50 0 1986 Federation of European Biochemical Societies 177 
Volume 204, number 2 FEBS LETTERS August 1986 
The aim of this study was to localize the effect of 
ANP within the glomerulus in the human species. 
Unexpectedly, we observed that ANP stimulated 
cGMP essentially in the epithelial cells. 
2. MATERIALS AND METHODS 
Synthetic rat ANP (Ser 128-Arg 150; atriopep- 
tin II) was donated by Ciba-Geigy (Basel, 
Switzerland) and synthetic human ANP (Ser 
124-Tyr 151) was purchased from Peninsula 
Laboratories (Belmont, CA). The following ra- 
dionuclides and reagents were obtained as in- 
dicated: 1251-tyrosine methyl ester cGMP and 1251- 
tyrosine methyl ester CAMP, the Radiochemical 
Centre (Amersham); cGMP and CAMP, Boeh- 
ringer (Mannheim); isobutylmethylxanthine 
(MIX), Sigma (St. Louis, MO); collagenase, 
Cooper Biomedical (Malvern, PA). 
Human glomerular epithelial and mesangial cells 
were cultured as described [ 121. Briefly, glomeruli 
were prepared from the cortex of human cadaver 
kidneys judged to be unsuitable for transplanta- 
tion. Isolated glomeruli were treated with col- 
lagenase (1 mg/ml) for 30 min at 37°C. Digested 
glomeruli were then passed on a 25 pm sieve. Re- 
tained glomeruli and filtered dissociated cells were 
resuspended separately in Waymouth’s medium 
supplemented with 20% human serum, 100 U/ml 
penicillin and lOOpg/ml streptomycin. The cells 
were plated on culture dishes and incubated at 
37°C in a humidified atmosphere of 5% CO2 in 
air. When outgrown, the cells were cloned in order 
to obtain pure preparations of mesangial and 
epithelial cells. Epithelial and mesangial cells were 
studied after 2-3 and 3-7 passages, respectively. 
They were plated on 6-well dishes (Nunclon; Nunc, 
Roskilde, Denmark) and used 48 h later. At this 
time each well contained approx. 200000 cells 
(200 pg protein). 
Epithelial and mesangial cells were identified 
from their morphological aspect and their syn- 
thetic functions. Further identification of each 
batch was provided using the immunofluorescence 
technique with an antikeratin antiserum (Miles, 
Paris) raised in guinea pig. Cells were grown on 
12-well multitest slides (Flow Labs, Puteaux, 
France) and fixed with acetone for 3 min. After 
several washings with phosphate-buffered saline, 
the cells were incubated with antikeratin an- 
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tiserum, washed again, and incubated with fluores- 
ceinated anti-guinea pig IgG. 
Cells were washed 3 times with Waymouth’s 
medium without human serum and incubated in 
situ at 37°C with 500~1 of Waymouth’s medium 
supplemented with 5 mM MgClz and 0.1 mM MIX 
in the presence of 0.1 nM-5 pM ANP. The reac- 
tion was stopped at 3 min, unless otherwise stated, 
by addition of 0.5 ml of 0.1 M HCI. cGMP and 
CAMP were measured in the HCI extract by 
radioimmunoassays. In some experiments the 
medium was collected and HCl was added 
separately to the medium and to the cells in order 
to measure intra- and extracellular cGMP. The 
samples were acetylated and aliquots of 25, 50 and 
100 ~1 were collected for radioimmunoassay. 
Acetylated samples and standards were incubated 
for 16 h at 4°C with either 1251-cGMP and the anti- 
cGMP antibody at 1: 200000 or ‘251-cAMP and the 
anti-CAMP antibody at 1:40000 (final dilutions). 
Both antibodies had been raised in the laboratory. 
It was verified they did not crossreact with ANP or 
MIX. The protein content of each well was 
measured according to Lowry et al. [13]. Results 
were expressed as pmol cGMP or CAMP per mg 
protein. 
The results shown in figs 2 and 4 were analysed 
using two factor analysis of variance with repeti- 
tion. The additive effect of ANP and sodium 
nitroprusside on cGMP production shown in fig.3 
was investigated using Student’s t-test. We com- 
pared the sum of the effects obtained separately 
with ANP and sodium nitroprusside with the ex- 
perimental value obtained when both agents were 
tested in combination. It was considered that the 
variance of the predicted sum was equal to the sum 
of the individual variances of its two components. 
3. RESULTS 
3.1. Cell identification 
The morphological characteristics of the two cell 
types in culture are shown in fig. 1. Epithelial cells 
are polyhedral with a cobblestone-like appearance 
at confluency whereas mesangial cells have a 
typical stellate appearance, pile up, and exhibit 
thin cytoplasmic extensions. In addition, the two 
human cell types were identified by their 
cytoskeleton proteins, specific response to several 
agonists and synthetic functions. Using the im- 
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Fig. 1. Morphological characteristics of cultured glomerular epithelial (A) and mesangial (B) cells. Magnification, x 450. 
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munofluorescence technique, epithelial cells 
stained markedly after incubation with a specific 
antikeratin antiserum whereas there was no 
staining with mesangial cells. Mesangial cells con- 
tracted in the presence of 1 nM angiotensin II or 
10 nM AVP whereas epithelial cells did not 1141. 
Epithelial cells synthesized predominantly type IV 
collagen whereas mesangial cells synthesized 
several types of collagen 115). Finally, epithelial 
cells synthesized and released in the incubation 
medium urokinase, an activator of pl~~nogen 
well characterized by its fibrin-independent activi- 
ty and i~ibition of this activity in the presence of 
specific antiurokinase antibody [16]. In contrast, 
human mesangial cells did not produce urokinase. 
3.2. Effect of ANP on cyclic GMP synthesis 
Mean basaI eGMP levels were 2.91 st 0.68 and 
3.81 1 1.17 (mean -f SE; n = 16) pmob’mg in 
epithelial and mesangial cells respectively. In 
epithelial cells, rANP markedly stimulated ac- 
cumulation of cGMP with a threshold between 1 
and 10 nM, and increasing stimulation up to 5 pM 
as shown in fig.2. At this concentration cGMP 
content was 20-times higher than its basal value. 
cGMP 
I (PmWms) 
Mesangial 
Fig.2 Effect of rat atrio~ptide on cGMP concentration Fig.3. Separate and cornb~~ effects of rat atriopeptide 
in glomerular epithelial (0) and mesangial (0) cells. (1 /rM) and sodium nitroprusside (1 mM) on cGMP 
Means f SE of the results of 4experiments (2values per con~ntra~ion in glomerular epithelial cells. Means f SE 
experiment) are shown. cGMP was measured after 3 min of the resuIts*of 3 experiments (2values per experiment) 
incubation. are shown. 
There was also an increase in cGMP in mesangial 
cells exposed to rANP but the response was con- 
siderably lower than in epithelial cells. A 2-fold 
stimulation was only observed with 5 pM rANP. It 
was verified that the response of mesangial cells 
did not change between the 3rd and 7th passage. 
Since we utilized glomerular cells from human 
origin we also studied the effects of hANP on 
cGMP accumulation in epithelial cells. hANP 
stimulated cGMP generation with a threshold dose 
of 10 nM, but stim~ation observed with 5 CM was 
IO-times the basal value, thus less than that ob- 
served using rANP. 
Sodium nitroprusside, a well-known activator of 
soluble guanylate cyclase without tissue specificity, 
produced at 1 mM a marked increase in cGMP 
formation in both glomerular cell types. However, 
stim~ation was more sub~~ti~ with epithelial 
(x IO-SO) than with mesangial cells (x 6-20). 
When studied in combination, rANP (1 FM) and 
sodium nitroprusside (I mM) produced an additive 
effect. Indeed, there was no significant difference 
between the value observed and the calculated sum 
of the separate effects of both agents (fig.3). 
To study the time course of cGMP production 
and release, cGMP accumulation with time was 
measured in parallel in the incubation medium and 
the epithelial cell extract under basal conditions 
BeSal ANP SNP ANP 
diF- 
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Fig.4. Accumulation of cGMP with time in the medium 
and the cell extract of glomerular epithelial cells 
incubated with (shaded bars) or without (open bars) 
1 PM rat atriopeptide. Means f SE of the results of 2 
experiments (2values per experiment) are shown. 
and in the presence of 1 ,uM rANP. The effect of 
this hormone was apparent after 3 min incubation. 
Intracellular cGMP decreased progressively with 
time and extracellular cGMP represented approx. 
70% of the total at 30 min (fig.4). 
Mean basal CAMP levels were 5.8 f 0.5 and 
8.9 + 2.3 (mean + SE; n = 12) pmol/mg in 
epithelial and mesangial cells, respectively. There 
was no change in the CAMP content of both cell 
types after 3 min incubation with 5 pM rANP. 
4. DISCUSSION 
Our findings indicate that ANP stimulates 
cGMP in human glomerular epithelial and 
mesangial cells. However, the response is con- 
siderably greater in epithelial than in mesangial 
cells. These results are thus different from those of 
Ballerman et al. [6] who reported that ANP- 
stimulated cGMP accumulation was predominant 
in rat cultured mesangial cells. These authors also 
observed that cell surface receptors for ANP were 
expressed on mesangial but not epithelial cells. 
However, they concluded that cGMP formation in 
mesangial cells was not directly coupled to the 
ANP receptors. The discordance between their 
study and ours may be due either to a species dif- 
ference or to the conditions of culture. It has been 
already shown that murine and human glomerular 
cells do not possess exactly the same synthetic 
functions. For example, rat mesangial and 
epithelial cells synthesize high levels of PGEz and, 
to a lesser extent, PGFh whereas PG production 
is very low in both human glomerular cell lines due 
to the lack of cyclooxygenase [ 171. We also studied 
cultured cells earlier (epithelial cells between the 
2nd and 3rd passage and mesangial cells between 
the 3rd and 7th passage) than did Ballerman et al. 
(both cell lines between the 12th and 20th passage). 
Furthermore, recent findings demonstrate that 
mesangial cells are not the only intra-glomerular 
target of ANP even in the rat. Bianchi et al. [18], 
using autoradiography techniques, reported that 
“‘1-ANP was present essentially in the endothelial 
cells. More recently the same group concluded 
from more precise ultrastructural studies that the 
majority of ANP receptors were localized in the 
visceral epithelial cells [7]. In agreement with these 
findings, Huang et al. [5] found a high concentra- 
tion of cGMP in the urinary Bowman’s space after 
administration of ANP in the rat. A mesangial 
source for this nucleotide would be unlikely since 
the products synthesized by the mesangial cells are 
excreted via the renal circulation. On the contrary, 
these experiments suggest that cGMP was 
generated by the epithelial cells which are directly 
in contact with the glomerular ultrafiltrate. It has 
also been shown [19] that administration of ANP 
in the rat produced a greater increase in the urinary 
excretion (lo-fold) than in the plasma concentra- 
tion (3%fold) of cGMP. The resulting increase 
(2.6-fold) in the renal clearance suggests a direct 
addition of the nucleotide to the tubular fluid. The 
tubular cells represent a possible origin since atria1 
extracts elevated cGMP in primary cultures of 
renal tubular cells [19]. However, the effect was 
less marked than that which we have observed with 
cultured glomerular epithelial cells in the present 
study. Furthermore, the study of fresh prepara- 
tions showed that the most striking action of ANP 
on cGMP occurred in the glomeruli (50-fold) and 
not in the tubular segments. Indeed, there was no 
effect in the proximal tubule [8,9] and only minor 
effects in the thick loop of Henle and the collecting 
duct [8]. It is thus possible that the excess of cGMP 
observed in the final urine may originate from the 
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glomerular epithelial cells. This hypothesis is 
strengthened by the recent results of Huang et al. 
[5], showing that the ratio cGMP concentration to 
inulin concentration did not change along the rat 
nephron including the final urine. The fact that 
cGMP formed in the cultured epithelial cells is 
rapidly released in the incubation medium is also in 
favor of this hypothesis. 
It is likely that ANP acts on the particulate 
guanylate cyclase in human glomerular epithelial 
cells similarly to what we reported with whole 
human glomeruli. Since it was not possible to 
study the increase in endogenous cGMP using 
subcellular fractions, we studied the separate and 
combined effects of rANP and nitroprusside on 
cGMP formation. We observed that addition of 
rANP, although at a dose which could not be con- 
sidered as providing the maximum response, fur- 
ther increased the effect of a maximally active dose 
(1 mM) of sodium nitroprusside. This result sug- 
gests that ANP and nitroprusside, a well-known 
stimulus of soluble guanylate cyclase, act on dif- 
ferent pools of cGMP. In accordance with the 
results of Umemura et al. [20] with rat isolated 
glomeruli, we found that ANP did not inhibit en- 
dogenous CAMP levels in glomerular epithelial 
cells. These results confirm that ANP operates in 
glomeruli only via activation of the particulate 
guanylate cyclase and not via inhibition of the cell 
membrane adenylate cyclase. 
ACKNOWLEDGEMENTS 
This work was supported by grants of the In- 
stitut National de la Sante et de la Recherche 
Medicale and of the Faculte de Mtdecine St. An- 
toine. We thank N. Knobloch and V. Brocherieu 
for secretarial assistance and J. Hagege for her 
help in the morphological studies. 
LETTERS August 1986 
REFERENCES 
111 
121 
131 
141 
151 
161 
[71 
PI 
PI 
WV 
illI 
WI 
u31 
1141 
WI 
[I61 
[I71 
WI 
WI 
WI 
Burnett, J.C. jr, Granger, J.P. and Opgenorth, 
T.J. (1984) Am. J. Physiol. 247, F863-F866. 
Huang, C.L., Lewicki, J., Johnson, L.K. and 
Cogan, M.G. (1985) J. Clin. Invest. 75, 769-773. 
Beasley, D. and Malvin, R.L. (1985) Am. J. 
Physiol. 248, F24-F30. 
Murray, R.D., Itoh, S., Inayami, T., Misono, K., 
Seto, S., Scicli, A.G. and Carretero, O.A. (1985) 
Am. J. Physiol. 249, F603-F609. 
Huang, C.L., Ives, H.E. and Cogan, M.G. (1986) 
Kidney Int. 29, 384 (Abstr.). 
Ballerman, B.J., Hoover, R.L., Karnovsky, M.J. 
and Brenner, B.M. (1985) J. Clin. Invest. 76, 
2049-2056. 
Carrier, F., Thibault, G., Schiffrin, E.L., Garcia, 
R., Gutkowska, J., Cantin, M. and Genest, J. 
(1985) Biochem. Biophys. Res. Commun. 133, 
666-673. 
Tremblay, J., Gerzer, R., Vinay, P., Pang, S.C., 
Beliveau, R. and Hamet, P. (1985) FEBS Lett. 181, 
17-22. 
Stokes, T.J. jr, McConkey, CL. jr and Martin, 
K.J. (1986) Am. J. Physiol. 250, F27-F31. 
Winquist, R. J., Faison, E.P., Waldman, S.A., 
Schwartz, K., Murad, F. and Rapoport, R.M. 
(1984) Proc. Natl. Acad. Sci. USA 81, 7661-7664. 
Harris, D.W., Baker, C.A., Saneii, H.H. and 
Johnson, G.A. (1985) Life Sci. 37, 591-597. 
Ardaillou, N., Nivez, M.P. and Ardaillou, R. 
(1985) FEBS Lett. 189, 8-12. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
Ardaillou, N., Hagege, J., Nivez, M.P., Ardaillou, 
R. and Schlondorff, D. (1985) Am. J. Physiol. 248, 
F240-F246. 
Striker, G.E., Killen, P.D. and Farin, F.M. (1980) 
Transplant. Proc. 12, 88-99. 
Angles-Cano, E., Rondeau, E., Delarue, F., 
Hagege, J., Sultan, Y. and Sraer, J.D. (1985) 
Thromb. Haemostasis 54, 688-692. 
Ardaillou, N., Nivez, M.P., Striker, G. and 
Ardaillou, R. (1983) Prostaglandins 26, 773-784. 
B@rchi, C., Gutkowska, J., Thibault, G., Garcia, 
R., Genest, J. and Cantin, M. (1985) 
Histochemistry 82, 441-452. 
Hamet, P., Tremblay, J., Pang, SC., Garcia, R., 
Thibault, G., Gutkowska, J., Cantin, M. and 
Genest, J. (1984) Biochem. Biophys. Res. Com- 
mun. 123, 515-527. 
Umemura, S., Smyth, D.D. and Pettinger, W.A. 
(1985) Biochem. Biophys. Res. Commun. 127, 
943-949. 
182 
